Topic: MS

Ofatumumab – update on long-term efficacy, safety

September 25, 2023  

K-index a predictor of T2 lesions in CIS, RIS

September 14, 2023  

TERIS trial: final results

September 7, 2023  

New ECTRIMS/EAN recommendations for vaccination in MS patients

September 5, 2023  

MicroRNAs – their potential as MS biomarkers

August 29, 2023  

Novel biomarkers in development for MS

August 14, 2023  

sNfL a useful alternative to gadolinium

July 31, 2023  

CLINICAL CASES IN MS – A DIAGNOSTIC DILEMMA

July 26, 2023  

Revised recommendations on the differential diagnosis of MS

July 25, 2023  

Lower risk of Gd+ lesions, new T2 lesions in older MS patients

July 18, 2023